These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6607226)

  • 21. Purine nucleoside modulation of functions of human lymphocytes.
    Priebe T; Platsoucas CD; Seki H; Fox FE; Nelson JA
    Cell Immunol; 1990 Sep; 129(2):321-8. PubMed ID: 1696525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymostimulin effects on lymphoid organs in Ames dwarf mice.
    Villanua MA; Szary A; Esquifino AI; Bartke A
    Acta Endocrinol (Copenh); 1993 Jan; 128(1):74-80. PubMed ID: 8447198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lectin-dependent cell-mediated cytotoxicity. A new and simple method to quantitate cytotoxic T cell activity in dogs.
    Emeson EE; Norin AJ; Veith FJ
    Transplantation; 1982 Apr; 33(4):365-9. PubMed ID: 6461955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of anti-tumor activity of natural killer cells by BALL-1, a B cell lymphoma line.
    Hirashima M; Yoshida N; Seki M; Okada H; Takamura S; Mihara Y
    Jpn J Cancer Res; 1998 Apr; 89(4):427-35. PubMed ID: 9617349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells.
    Baccarini M; Scaringi L; Puccetti P; Falchetti R; D'Errico P; Bistoni F
    Int J Tissue React; 1984; 6(6):485-92. PubMed ID: 6530352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of proliferative and cytotoxic responses to interleukin 2 and concanavalin A in murine fetal thymus.
    Teh HS; Ho M
    J Immunol; 1985 Mar; 134(3):1653-8. PubMed ID: 3871454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
    Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
    Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis.
    O'Brien CJ; Nouri-Aria KT; Hegarty JE; Vento S; Eddleston AL; Williams R
    Int J Immunopharmacol; 1988; 10(6):651-6. PubMed ID: 2974021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
    Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
    Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of immune response and tumor development in tumor-bearing mice treated by the thymic factor thymostimulin.
    Klein AS; Lang R; Eshel I; Sharabi Y; Shoham J
    Cancer Res; 1987 Jul; 47(13):3351-6. PubMed ID: 2438037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of thymic hormone (THF) and of a thymic plasma recirculating factor (TPRF) in the modulation of human lymphocyte response to PHA and Con A.
    Rotter V; Trainin N
    J Immunol; 1979 Feb; 122(2):414-20. PubMed ID: 216747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulatory effects of sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes.
    Yoneda K; Ueta E; Yamamoto T; Osaki T
    Clin Exp Immunol; 1991 Nov; 86(2):229-35. PubMed ID: 1657462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells.
    Perl A; Gonzalez-Cabello R; Láng I; Gergely P
    Cell Immunol; 1984 Mar; 84(1):185-93. PubMed ID: 6230158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of bovine lymphocytes after treatment with lymphokines.
    Campos M; Rossi CR
    Am J Vet Res; 1986 Jul; 47(7):1524-8. PubMed ID: 3488701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic capabilities of bovine lymphocytes after lectin stimulation.
    Campos M; Rossi CR
    Vet Immunol Immunopathol; 1987 Apr; 14(4):297-307. PubMed ID: 3496708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.
    Shou L; Schwartz SA; Good RA
    J Exp Med; 1976 May; 143(5):1100-10. PubMed ID: 131175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
    Nio Y; Zighelboim J; Berek JS; Bonavida B
    Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.